Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Bema Fentanyl (Exclusive American Rights)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

A pharmaceutical drug rights in United States, Canada and Mexico. The asset consists of a drug rights of Bema Fentanyl utilized for the purpose of paint treatment for cancer patients.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Commercial Services
Other Industries
Pharmaceuticals
Acquirer

Bema Fentanyl (Exclusive American Rights) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Bema Fentanyl (Exclusive American Rights)‘s full profile, request access.

Request full access to PitchBook